Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial

OBJECTIVE: To explore non-steroidal anti-inflammatory drug (NSAID) and analgesic use in early rheumatoid arthritis (eRA) patients with a favourable risk profile initiating methotrexate (MTX) with or without glucocorticoid (GC) bridging. METHODS: Patients with eRA (≤1 year) and favourable risk profil...

Descripción completa

Detalles Bibliográficos
Autores principales: Pazmino, Sofia, Boonen, Annelies, De Cock, Diederik, Stouten, Veerle, Joly, Johan, Bertrand, Delphine, Westhovens, René, Verschueren, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149441/
https://www.ncbi.nlm.nih.gov/pubmed/34031262
http://dx.doi.org/10.1136/rmdopen-2021-001615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149441/
https://www.ncbi.nlm.nih.gov/pubmed/34031262
http://dx.doi.org/10.1136/rmdopen-2021-001615

Ejemplares similares